![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1516375
³»½Ã°æ ÇùÂø °ü¸® ±â±â ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2024-2032³â)Endoscopic Stricture Management Device Market - Product (Stents, Balloon Dilators, Balloon Inflation Devices, Bougie Dilators), Application (Esophageal, Colonic, Biliary), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast (2024 - 2032) |
³»½Ã°æ ÇùÂø °ü¸® ±â±â ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 5.8% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Å©·Ðº´, ½Äµµ ÇùÂøÁõ µî ¼Òȱâ ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ È¿°úÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ±¹¸³ÀÇÇеµ¼°ü ÀÚ·á¿¡ µû¸£¸é, 2030³â±îÁö À¯·´°ú ¹Ì±¹¿¡¼ 700¸¸ ¸í ÀÌ»óÀÌ ¿°Áõ¼º ÀåÁúȯ(IBD)À» ¾Î°Ô µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³»½Ã°æÀÇ È¹±âÀûÀÎ ¹ßÀüÀ¸·Î ÇùÂø °ü¸®ÀÇ Á¤È®¼º, È¿°ú ¹× ¾ÈÀü¼ºÀÌ Çâ»óµÇ¾î äÅ÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ¼Òȱâ Áúȯ¿¡ ´ëÇÑ Àνİú Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ÀÌ·¯ÇÑ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúȯ¿¡ Ãë¾àÇÑ ¼¼°è Àα¸ÀÇ °í·Éȵµ Á¦Ç° Ãâ½Ã¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ȸº¹ ½Ã°£À» ´ÜÃàÇϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ ÀÌ·¯ÇÑ Àåºñ°¡ Á¦°øÇÏ´Â ÃÖ¼Ò Ä§½ÀÀû ½Ã¼úµµ ÀÌ·¯ÇÑ Àåºñ¸¦ ¼±È£ÇÏ°Ô ¸¸µå´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. À¯¸®ÇÑ ±ÔÁ¦ ½ÂÀÎ, ÀÇ·áºñ ÁöÃâ Áõ°¡ ¹× »óȯ Á¤Ã¥Àº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Á¦Ç°º°·Î´Â dz¼± È®Àå±â°¡ ÃÖ¼ÒÇÑÀÇ Ä§½ÀÀ¸·Î ÇùÂøÀ» Ä¡·áÇÒ ¼ö Àֱ⠶§¹®¿¡ dz¼± È®Àå±â ºÎ¹®ÀÇ ³»½Ã°æÀû ÇùÂø °ü¸® ±â±â ½ÃÀåÀº 2024³âºÎÅÍ 2032³â±îÁö ´«¿¡ ¶ç´Â ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ¼ÒȰü ÇùÂø ºÎÀ§¸¦ Á¤È®ÇÏ°Ô È®ÀåÇÏ´Â µ¿½Ã¿¡ ¼ö¼úÀÇ Çʿ伺À» ÁÙÀ̰í ȯÀÚÀÇ È¸º¹À» ÃËÁøÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ±Þ¼ÓÇÑ ¹ßÀüÀ¸·Î ¾ÈÀü¼º°ú À¯È¿¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¼ÒȰü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °í±Þ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÇ·á Àü¹®°¡µéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ Á¦Ç° ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
Å©·Ðº´, ´ëÀå¾Ï°ú °°Àº ´ëÀå ÁúȯÀÇ ¹ßº´·ü Áõ°¡¿¡ ÈûÀÔ¾î ´ëÀå ³»½Ã°æÀû ÇùÂø °ü¸® ±â±â »ê¾÷Àº 2032³â±îÁö Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÎ½Ä Áõ°¡¿Í Á¶±â Áø´ÜÀÌ È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ³»½Ã°æ ÀåºñÀÇ ±â¼ú °³¹ßÀº Á¤È®µµ¿Í ȯÀÚ ¿¹Èĸ¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. Àúħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿Í °í·ÉÈ Àα¸ Áõ°¡´Â ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Áö¿ªº°·Î º¸¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³»½Ã°æÀû ÇùÂø °ü¸® ±â±â ½ÃÀåÀº ¼Òȱâ ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ÁöÃâ Áõ°¡, ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë¿¡ ÈûÀÔ¾î 2024³âºÎÅÍ 2032³â±îÁö °·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼Òȱâ Áúȯ¿¡ ´ëÇÑ Àνİú Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ Áö¿ª¿¡¼ ÀÌ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àα¸ °í·ÉÈ¿Í ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ Ã¤Åà Áõ°¡µµ ÀÌ Áö¿ªÀÇ »ê¾÷ ¹ßÀüÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.
Endoscopic Stricture Management Device Market size is projected to grow at 5.8% CAGR between 2024 and 2032. The rising prevalence of gastrointestinal disorders, such as Crohn's disease and esophageal strictures, is necessitating several effective treatment solutions. According to data from the National Library of Medicine, more than 7 million people in Europe and the U.S. will be suffering from inflammatory bowel diseases (IBD) by 2030. Significant advancements in endoscopy are enhancing the precision, efficacy, and safety of stricture management, leading to increasing adoption rates.
The growing awareness and early diagnosis of gastrointestinal conditions is also spurring the demand for these devices. The aging global population, which is more prone to such disorders is also increasing the product deployment. Minimally invasive procedures offered by these devices to reduce recovery times and improve patient outcomes is also making them a preferred choice. The favorable regulatory approvals, increasing healthcare expenditure, and reimbursement policies are further driving the market growth.
The overall market is segregated into product, application, end-user, and region.
Based on product, the endoscopic stricture management device market from the balloon dilators segment will grow at notable pace between 2024 and 2032, on account of their effectiveness in treating strictures with minimal invasiveness. These devices offer precise dilation of narrowed areas in the gastrointestinal tract while reducing the need for surgery and enhancing patient recovery. Rapid advancements are improving their safety and efficacy. The increasing prevalence of gastrointestinal disorders and the rising awareness among healthcare professionals about advanced treatment options are fueling the product demand.
Endoscopic stricture management device industry from the colonic application segment is estimated to grow at significant rate up to 2032, led by the rising incidence of colorectal diseases, such as Crohn's disease and colorectal cancer. The increasing awareness and early diagnosis are driving the demand for effective treatment options. Technological developments in endoscopic devices are improving precision and patient outcomes. The rising preference for minimally invasive procedures and the growing aging population will further boost the segment growth.
Regionally, the Asia Pacific endoscopic stricture management device market will showcase strong gains between 2024 and 2032, driven by the rising prevalence of gastrointestinal disorders, increasing healthcare expenditure, and expanding access to advanced medical technologies. The growing awareness and early diagnosis of gastrointestinal conditions is boosting the demand for these devices in the region. The aging population and the increasing adoption of minimally invasive procedures will also push the regional industry progression.